Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: A study level and a patient level network meta-analysis
10.1186/1471-2466-12-29
Saved in:
Main Authors: | Cope S., Zhang J., Williams J., Jansen J.P. |
---|---|
Other Authors: | INTERACTIVE & DIGITAL MEDIA INSTITUTE |
Format: | Article |
Published: |
BioMed Central
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/143937 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Areal-world evaluation of indacaterol and other bronchodilators in COPD: The INFLOW study
by: Georges Juvelekian, et al.
Published: (2018) -
Areal-world evaluation of indacaterol and other bronchodilators in COPD: The INFLOW study
by: Georges Juvelekian, et al.
Published: (2018) -
Indacaterol for Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis
by: Chung V.C.H., et al.
Published: (2018) -
Comparative efficacy and safety of pitavastatin 1 MG once daily dose versus atorvastatin 10 MG once daily dose in outpatients with hypercholesterolemia
by: Pawat Putwai
Published: (2012) -
Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir
by: Weerawat Manosuthi, et al.
Published: (2018)